Literature DB >> 11722596

Clinical findings and magnetic resonance imaging in severe cyclosporine-related neurotoxicity after allogeneic bone marrow transplantation.

F Trullemans1, F Grignard, B Van Camp, R Schots.   

Abstract

OBJECTIVES: Severe neurotoxicity is a recognized complication of cyclosporin A (cyclosporine, CSA). Neuroimaging studies typically show reversible brain lesions, predominantly confined to the white matter. Our aim was to delineate clinical characteristics and to specify results of magnetic resonance imaging (MRI) and computerised tomography (CT) scan findings.
METHODS: Cases of severe cyclosporine-related neurotoxicity (SNCT) were identified among a series of 129 consecutive allogeneic transplant recipients. Clinical features were analysed, including CSA levels, electrolytes, cholesterolemia and magnesemia. MRI and/or CT scans were obtained within 24 h to 4 d after the onset of neurotoxicity.
RESULTS: Six patients (4.6%) developed a prodromal phase (headache and/or hypertension), followed by SCNT, including generalized seizures (n = 5), occipital blindness (n = 1) and hemiparesis (n = 1). There was no correlation between the laboratory findings and the onset of SNCT. All patients were on corticosteroid treatment. MRI studies showed hyperintensity lesions, predominantly in the posterior cerebrum, with both subcortical and cortical involvement in 4 out of 5 patients. Cerebellar involvement (n = 4) was also a frequent finding. The signal abnormalities, corresponding to the anastomotic border zones between major cerebral and cerebellar arteries, were limited to the respective cortical areas.
CONCLUSION: Association of corticosteroids is a trigger in the development of SCNT. MRI is recommended for the early identification of the transient brain lesions in patients with a prodromal phase. The more specific distribution of the lesions in the anastomotic border zones suggests vascular injury as a contributing factor in the pathology of SNCT.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11722596     DOI: 10.1034/j.1600-0609.2001.t01-1-00440.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  20 in total

1.  Enhanced Long-Term Brain Magnetic Resonance Imaging Evaluation of Children with Sickle Cell Disease after Hematopoietic Cell Transplantation.

Authors:  Nancy S Green; Monica Bhatia; Erica Y Griffith; Mahvish Qureshi; Courtney Briamonte; Mirko Savone; Stephen Sands; Margaret T Lee; Angela Lignelli; Adam M Brickman
Journal:  Biol Blood Marrow Transplant       Date:  2017-01-09       Impact factor: 5.742

2.  Rapid, low-cost MR imaging protocol to document central nervous system and sinus abnormalities prior to pediatric hematopoietic stem cell transplantation.

Authors:  Eliane D Leite; Adriana Seber; Felipe G de Barbosa; Valeria C Ginani; Fabianne C Carlesse; Roseane V Gouvea; Victor G Zecchin; Cinthya R Carvalho; Gilberto Szarf; Henrique M Lederman
Journal:  Pediatr Radiol       Date:  2011-02-02

3.  The use of cyclosporine in a boy with a prior episode of posterior encephalopathy.

Authors:  Chieko Nakahara; Naoyuki Hasegawa; Isho Izumi; Katsuyosi Kanemoto; Nobuaki Iwasaki
Journal:  Pediatr Nephrol       Date:  2005-02-17       Impact factor: 3.714

4.  Posterior reversible encephalopathy syndrome in patients with hematologic tumor confers worse outcome.

Authors:  Hui Li; Ying Liu; Jing Chen; Xia Tan; Xiu-Yun Ye; Ming-Sheng Ma; Jian-Ping Huang; Li-Ping Zou
Journal:  World J Pediatr       Date:  2015-06-04       Impact factor: 2.764

5.  Posterior reversible encephalopathy syndrome (PRES): electroencephalographic findings and seizure patterns.

Authors:  Oliver Kastrup; Markus Gerwig; Markus Frings; Hans-Christoph Diener
Journal:  J Neurol       Date:  2011-12-22       Impact factor: 4.849

6.  High incidence of severe cyclosporine neurotoxicity in children affected by haemoglobinopaties undergoing myeloablative haematopoietic stem cell transplantation: early diagnosis and prompt intervention ameliorates neurological outcome.

Authors:  Anna Noè; Barbara Cappelli; Alessandra Biffi; Robert Chiesa; Ilaria Frugnoli; Erika Biral; Valentina Finizio; Cristina Baldoli; Paolo Vezzulli; Fabio Minicucci; Giovanna Fanelli; Rossana Fiori; Fabio Ciceri; Maria Grazia Roncarolo; Sarah Marktel
Journal:  Ital J Pediatr       Date:  2010-02-06       Impact factor: 2.638

7.  Medication neurotoxicity in children.

Authors:  Ramesh S Iyer; Apeksha Chaturvedi; Sumit Pruthi; Paritosh C Khanna; Gisele E Ishak
Journal:  Pediatr Radiol       Date:  2011-07-23

8.  Emergent Complications in the Pediatric Hematopoietic Stem Cell Transplant Patient.

Authors:  Ashley Munchel; Allen Chen; Heather Symons
Journal:  Clin Pediatr Emerg Med       Date:  2011-09

Review 9.  The central nervous system complications of bone marrow transplantation in children.

Authors:  Shoko Yoshida; Katsumi Hayakawa; Akira Yamamoto; Hiroshi Kuroda; Shinsaku Imashuku
Journal:  Eur Radiol       Date:  2008-05-20       Impact factor: 5.315

Review 10.  Epileptic Seizures After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Zhuo Wang; Munan Zhao; Sujun Gao
Journal:  Front Neurol       Date:  2021-07-16       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.